Funded Health Care Startups in Ireland
Among the 40 most recent health care rounds in Ireland, the largest disclosed amount is ProVerum Medical’s $80M Series B on 2025-08-25.
Among the 40 most recent health care rounds in Ireland, the largest disclosed amount is ProVerum Medical’s $80M Series B on 2025-08-25. That single round dwarfs the next-largest disclosed amounts in the table ($33M DeepVerge on 2022-03-19 and $125M Amryt Pharma on 2022-02-22 are larger than $80M, but note that the maximum disclosed in the rows is Amryt Pharma’s $125M on 2022-02-22; below that, $80M is the standout most recent disclosed high). Most entries cluster in Dublin and nearby counties: Dublin-based companies like ProVerum Medical (2025-08-25, $80M), CroíValve (2025-07-01, $3M) and Novus Diagnostics (2025-01-15, $5M) sit alongside Galway (e.g., NUA Surgical $7M on 2024-12-06) and Cork (e.g., SAOL $220K on 2023-11-22). Stage labels are mixed: 13 of 40 rows are “Series Unknown” and an additional five rows list “undisclosed,” creating a material classification gap that concentrates interpretive uncertainty around round type. Temporally, the dataset spans 2020-09-23 (MEG Support Tools, $500K) through 2025-08-25, with multiple Dublin rounds landing in early 2025 (e.g., SISU Aesthetic Clinic $15M on 2025-01-08 and LaNua Medical $6M on 2024-12-12).
Most recent rounds
40 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Ireland health care set, and how far above the rest is it?
The largest disclosed amount is Amryt Pharma’s $125M on 2022-02-22 (Post-IPO Debt), which is well above the next-largest disclosed amounts shown such as DeepVerge’s $33M on 2022-03-19 and Atlantic Therapeutics’ $20M on 2022-01-20.
Do any cities appear over-represented, based on the rounds and amounts shown?
Dublin is the dominant geography across recent and older entries, including ProVerum Medical ($80M, 2025-08-25), CroíValve ($3M, 2025-07-01), Spectrum Life ($18M, 2024-05-27), and OneProjects ($8M, 2021-10-14). Galway and Cork also recur (e.g., NUA Surgical $7M on 2024-12-06 in Galway; SAOL $220K on 2023-11-22 in Cork), but with fewer high-dollar anchors.
Which entries fall within the most recent ~90 days of the latest row date?
Relative to the latest date in the table (2025-08-25), the most recent cluster includes ProVerum Medical on 2025-08-25 ($80M), CroíValve on 2025-07-01 ($3M), and Novus Diagnostics on 2025-01-15 ($5M) is outside that 90-day window. Within the year-start window closest to that, SISU Aesthetic Clinic (2025-01-08, $15M) and Vida Care (2025-01-07, $1M) show early-2025 follow-ons.
How much does stage/amount classification uncertainty affect analysis here?
Thirteen of 40 rows are labeled “Series Unknown,” and five list “undisclosed” amounts (for example Neurent Medical on 2024-12-18, and My Moves Matter on 2023-07-04). That means comparisons by stage are constrained, since several of the most recent entries (like CroíValve’s $3M on 2025-07-01 with “Series Unknown”) cannot be cleanly grouped by a consistent round taxonomy.
Are there notable outliers besides the largest round, such as unusually small disclosed amounts or distinct round types?
The smallest disclosed amount is SAOL’s $220K on 2023-11-22 (Seed), which sits far below many other disclosed rounds in the $1M–$10M band (e.g., Gasgon Medical $2M on 2022-04-26; Versono Medical $7M on 2022-12-13). On round type, “Post-IPO Debt” appears with large disclosed sizes such as Amryt Pharma ($125M, 2022-02-22) and DeepVerge ($33M, 2022-03-19), forming a distinct high-dollar subgroup.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.